A carregar...
Edoxaban in patients with atrial fibrillation
Edoxaban, a direct factor Xa inhibitor, was extensively studied in the prevention and treatment of venous thromboembolism and in patients with nonvalvular atrial fibrillation (AF). The aim of this review is to focus specifically on the efficacy and safety profile of edoxaban in patients with AF from...
Na minha lista:
| Publicado no: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942795/ https://ncbi.nlm.nih.gov/pubmed/26680560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944715622130 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|